Home/CEL-SCI/Geert R. Kersten
GR

Geert R. Kersten

Chief Executive Officer

CEL-SCI

CEL-SCI Pipeline

DrugIndicationPhase
Multikine (Leukocyte Interleukin, Injection)Advanced Primary Head and Neck CancerPhase 3
LEAPS PlatformRheumatoid Arthritis, other Autoimmune & Infectious DiseasesPreclinical/Discovery